tirzepatide news october 2025 ADA 2025: Advances in Type 2 Diabetes Management With Cardiovascular outcomes of semaglutide and

Is BPC-157 FDA Approved in 2026

author, Raising Body-Confident Kids and My One-Of A-Kind Body: The Ultimate Guide to Caring for Me Angela Corral, senior editor, KQEDs The California Report

The Bottom Line Perimenopause and menopause weight gain stem from hormonal changes that can make traditional weight loss approaches feel like an uphill battle

More research should be done to monitor side effects and see if it also has the benefits of other GLP-1 medications, such as preventing cardiac events, Mir Ali, MD, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, agreed

Meanwhile, natural products hold significant potential in regulating ferroptosis and maintaining ovarian function